CMS 156v11: Use of High-Risk Medications in Older Adults

Measure: Percentage of patients 65 years of age and older who were ordered at least two high-risk medications from the same drug class. Three rates are reported:

  • Percentage of patients 65 years of age and older who were ordered at least two high-risk medications from the same drug class

  • Percentage of patients 65 years of age and older who were ordered at least two high-risk medications from the same drug class, except for appropriate diagnoses

  • Total rate (the sum of the two numerators divided by the denominator, deduplicating for patients in both numerators)

Measure Type High Priority Measure Scoring
Process Yes A lower percentage indicates better quality
Denominator Patients 65 years and older at the end of the measurement period who had a visit during the measurement period
Numerator

Rate 1 : Patients with at least two orders of high-risk medications from the same drug class on different days

  1. At least two orders of high-risk medications from the same drug class

  2. At least two orders of high-risk medications from the same drug class with summed days supply greater than 90 days

  3. At least two orders of high-risk medications from the same drug class each exceeding average daily dose criteria

Rate 2: Patients with at least two orders of high-risk medications from the same drug class (i.e., antipsychotics and benzodiazepines) on different days

Total rate (the sum of the two previous numerators, deduplicated)

Denominator Exceptions None
Denominator Exclusions
  • Patients in hospice care for any part of the measurement period

  • Patients receiving palliative care for any part of the measurement period

Numerator Exclusions

Rate 2: For patients with two or more antipsychotic prescriptions ordered, exclude patients who have a diagnosis of schizophrenia, schizoaffective disorder, or bipolar disorder on or between January 1 of the year prior to the measurement period and the Index Prescription Start Date (IPSD) for antipsychotics

For patients with two or more benzodiazepine prescriptions ordered, exclude patients who have a diagnosis of seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, or severe generalized anxiety disorder on or between January 1 of the year prior to the measurement period and the IPSD for benzodiazepines

 

Return to 2023 eCQMs

 

Didn't find the answer you were looking for?

Contact Sevocity Support 24/7 at 877‑777‑2298 or support@sevocity.com